Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.17
-0.03 (-0.42%)
Jun 12, 2026, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 115.88 million as of June 12, 2026. Its market cap has decreased by -27.58% in one year.
Market Cap
115.88M
Enterprise Value
134.27M
Revenue
17.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.17
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 115.88M, an increase of 24.59%. That is a compound annual growth rate of 1.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 115.88M | 2.72% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 501.28M |
| Bioceltix | 495.14M |
| Ryvu Therapeutics | 355.59M |
| BIOTON | 342.60M |
| Syn2bio | 287.54M |
| Synthaverse | 208.37M |
| Molecure | 117.44M |
| Poltreg | 114.48M |